Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2008
Severe diarrhea caused by cholera toxin-producing vibrio cholerae serogroup O75 infections acquired in the southeastern United StatesMelissa Tobin-D'Angelo, Allison R Smith, Sandra N Bulens, et al.
Obstetrics and Gynecology|May 3, 2014
Early-onset group B streptococcal disease in the United States: potential for further reductionJennifer R Verani, Nancy L Spina, Ruth Lynfield, et al.
Infection Control and Hospital Epidemiology|June 11, 2014
On-site availability of Legionella testing in acute care hospitals, United StatesLaurel E Garrison, Kristin M S Shaw, Jeffrey T McCollum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2021
Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018Jeremy A W Gold, Emma E Seagle, Joelle Nadle, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|July 28, 2026
Active Surveillance for Invasive Mold Disease - Four Hospitals, Atlanta, Georgia, 2020-2024Elizabeth T Sajewski, Carolyn Mackey, Stepy Thomas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 29, 2020
Burden of Candidemia in the United States, 2017Sharon V Tsay, Yi Mu, Sabrina Williams, et al.
The Lancet. Microbe|February 26, 2026
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceKatherine E Gallagher, Fredrick Odiwour, Christian Bottomley, et al.
Nature Communications|October 23, 2025
A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reductionJulia C Rhodes, Rebecca Kahn, Shanna Bolcen, et al.
Pageof 3